Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
45 participants
OBSERVATIONAL
2024-06-25
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Diabetes Prevention Study Targeting High Risk Individuals With Education and Ongoing Support
NCT00677937
Assessment of Response Rates and Yields for Two Tools for Early Detection of Non-diabetic Hyperglycaemia and Diabetes
NCT00950313
Effectiveness and Cost-Effectiveness of Fully-Automated Digital vs. Human Coach-Based Diabetes Prevention Programs
NCT05056376
Comparison Study of Usual Care vs. Usual Care Plus Community Intervention to Manage Type 2 Diabetes
NCT02158741
Family Diabetes Prevention Program Pilot Study
NCT05358444
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Using a successful approach from previous research, and experience from existing online diabetes classification calculators, we will test the feasibility of developing a decision support tool that would run the algorithms in these calculators on electronic healthcare record data at participating GP sites. We will work with a company that will develop a decision support tool that will search and extract relevant healthcare data in GP systems, run our algorithms on these data, and produce a display, highlighting patient records where there is a potential misclassification of diabetes and/or records where there are potential data quality issues (e.g. mis-coding or missing information). The decision support tool will only run on extracted data (rather than being embedded in the GP system).
Participating GP sites will be offered an introductory education session on classification of diabetes subtypes and identification of MODY (Maturity Onset Diabetes of the Young) and training on running and interpreting the decision tool.
On receipt of the outputs from the decision support tool, practice staff will be advised to review the records of potentially misclassified patients to explore any mis-codings and to consider further testing/referrals as relevant and in line with the standard clinical care pathway for diabetes.
At the end of the study, the data extraction/decision support tool may be re-run to determine whether there have been changes and whether additional testing (eg C-peptide or islet autoantibody) or referral to a diabetes specialist team has been carried out.
Part 2:
To assess the acceptability of the diabetes classification tools to potential users, and to consider how best to implement them in clinical practice long term for maximum benefit, we will explore the views and experiences of general practice teams and people with diabetes on the use of the diabetes classification tools.
A sample of clinical and admin staff at participating GP sites, and diabetes patients flagged by the tool as misclassified, will be invited to take part in a semi-structured interview about their views \& experience.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients qualitative interviews
1. Patients reviewed by their GP as a result of Stage 1 (running of tool) are invited to a qualitative interview.
2. Consenting participants interviewed by the research team.
3. Information used to assess the impact and potential benefit of using the diabetes classification tool in general practice.
Qualitative interview (patients)
Qualitative interviews to be carried out by an experienced researcher with patients who have had their diabetes diagnosis reviewed as a result of the running of the tool.
Practice staff qualitative interviews
1. Practice staff (clinical and administrative) who have been involved in Stage 1 (running of tool) are invited to a qualitative interview.
2. Consenting participants interviewed by the research team.
3. Information used to assess the impact and potential benefit of using the diabetes classification tool in general practice.
Qualitative interview (staff)
Qualitative interviews to be carried out by an experienced researcher with practice staff who have run the tool and reviewed patients flagged by the tool.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Qualitative interview (patients)
Qualitative interviews to be carried out by an experienced researcher with patients who have had their diabetes diagnosis reviewed as a result of the running of the tool.
Qualitative interview (staff)
Qualitative interviews to be carried out by an experienced researcher with practice staff who have run the tool and reviewed patients flagged by the tool.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to give written informed consent
* 18 years of age or over at the time of study participation
* Diabetes diagnosed at or under the age of 50
* Registered with a participating GP practice
* Sufficient understanding of the English Language to enable completion of the interview
Staff
* Able to give written informed consent
* 18 years of age or over
* Working at a participating General Practice and directly involved with the study procedures (eg running the decision support tool, responsibility for clinical care of diabetes patients)
Exclusion Criteria
* Unable to give written informed consent
* Under 18 years of age
* No diabetes or diabetes diagnosed over the age of 50.
* Not registered with a participating GP practice
* Insufficient understanding of the English Language to enable interview completion
* Have an opt-out code where patient has declined electronic medical records examined
* Considered by their General Practitioner(s) to be inappropriate to recruit due to psycho-social reasons, participating in another related clinical trial or significant health reasons, e.g. terminal illness/diagnosis.
Staff
* Unable to give written informed consent
* Under 18 years of age
* General Practice staff not involved with the study procedures.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Bristol
OTHER
University of Nottingham
OTHER
National Institute for Health Research, United Kingdom
OTHER_GOV
University of Exeter
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Beverley Shields, Professor
Role: PRINCIPAL_INVESTIGATOR
University of Exeter
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tamar Valley Health
Plymouth, Cornwall, United Kingdom
Ivybridge Medical Practice (Beacon Medical Group)
Ivybridge, Devon, United Kingdom
Roborough Surgery
Plymouth, Devon, United Kingdom
Pathfields Medical Group
Plymouth, Devon, United Kingdom
Plympton Health Centre (Beacon Medical Group)
Plymouth, Devon, United Kingdom
Chaddlewood Surgery (Beacon Medical Group)
Plymouth, Devon, United Kingdom
Hucknall Road Medical Centre
Nottingham, Nottinghamshire, United Kingdom
Parkside Medical Practice
Nottingham, Nottinghamshire, United Kingdom
Chilwell Valley and Meadows Practice
Nottingham, Nottinghamshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-23-18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.